Skip to main content
. 2016 Dec 7;11:170–175. doi: 10.1016/j.redox.2016.12.006

Fig. 2.

Fig. 2

Caspase 3 activity following treatment of cisplatin in combination with caffeic acid for 48 h (a) Caspase 3 activity in A2780 cells (b) and in A2780cisR cells. Data represented as % control (untreated cells)±SD; *, †, ‡ indicates signnificance (p<0.05) comparing to treatment of cisplatin alone at concentrations of 5,10,20 µM, respectivley.